Does lovastatin lower serum cholesterol levels in non-insulin-dependent diabetes mellitus patients without altering their insulin sensitivity?
The results demonstrated that lovastatin significantly lowered the serum TC levels without perturbation of insulin sensitivity in hypercholesterolemic NIDDM patients.
It seems that the preventive effect of captopril is not directly mediated by K(ATP) channels and further attention should be paid to other receptor-mediated angiotensin II effects.